FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980772806> ?p ?o ?g. }

• W2980772806 endingPage "e0223603" @default.
• W2980772806 startingPage "e0223603" @default.
• W2980772806 abstract "Information is needed on the safety of adalimumab when used in pregnancy for the treatment of certain autoimmune diseases.Between 2004 and 2016, the Organization of Teratology Information Specialists Research Center at the University of California San Diego conducted a prospective controlled observational cohort study in 602 pregnant women who had or had not taken adalimumab. Women in the adalimumab-exposed cohort had received at least one dose of the drug in the first trimester for the treatment of rheumatoid arthritis or Crohn's Disease (N = 257). Women in the disease comparison cohort had not used adalimumab in pregnancy (N = 120). Women in the healthy comparison cohort had no rheumatic or inflammatory bowel diseases (N = 225). Women and their infants were followed to one year postpartum with maternal interviews, medical records abstraction, and physical examinations. Study outcomes were major structural birth defects, minor defects, spontaneous abortion, preterm delivery, pre and post-natal growth deficiency, serious or opportunistic infections and malignancies. 42/602 (7.0%) of pregnancies were lost-to-follow-up. 22/221 (10.0%) in the adalimumab-exposed cohort had a live born infant with a major birth defect compared to 8/106 (7.5%) in the diseased unexposed cohort (adjusted odds ratio 1.10, 95% confidence interval [CI] 0.45 to 2.73). Women in the adalimumab-exposed cohort were more likely to deliver preterm compared to the healthy cohort (adjusted hazard ratio [aHR] 2.59, 95% CI 1.22 to 5.50), but not compared to the diseased unexposed cohort (aHR 0.82, 95% CI 0.66 to 7.20). No significant increased risks were noted with adalimumab exposure for any other study outcomes.Adalimumab exposure in pregnancy compared to diseased unexposed pregnancies was not associated with an increased risk for any of the adverse outcomes examined. Women with rheumatoid arthritis or Crohn's Disease were at increased risk of preterm delivery, irrespective of adalimumab exposure." @default.
• W2980772806 created "2019-10-25" @default.
• W2980772806 creator A5007438752 @default.
• W2980772806 creator A5034436437 @default.
• W2980772806 creator A5044655005 @default.
• W2980772806 creator A5060521446 @default.
• W2980772806 creator A5064343783 @default.
• W2980772806 creator A5074889361 @default.
• W2980772806 creator A5074893779 @default.
• W2980772806 creator A5079544697 @default.
• W2980772806 creator A5079796813 @default.
• W2980772806 creator A5091189663 @default.
• W2980772806 date "2019-10-18" @default.
• W2980772806 modified "2023-10-16" @default.
• W2980772806 title "Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study" @default.
• W2980772806 cites W1495532091 @default.
• W2980772806 cites W1606580957 @default.
• W2980772806 cites W1618589227 @default.
• W2980772806 cites W1622670858 @default.
• W2980772806 cites W1704544013 @default.
• W2980772806 cites W1836738882 @default.
• W2980772806 cites W1946352393 @default.
• W2980772806 cites W1969479683 @default.
• W2980772806 cites W2016756483 @default.
• W2980772806 cites W2056106279 @default.
• W2980772806 cites W2060602500 @default.
• W2980772806 cites W2067073937 @default.
• W2980772806 cites W2145860140 @default.
• W2980772806 cites W2324859219 @default.
• W2980772806 cites W2463271173 @default.
• W2980772806 cites W2498599964 @default.
• W2980772806 cites W2796381406 @default.
• W2980772806 cites W2804568213 @default.
• W2980772806 cites W2905695985 @default.
• W2980772806 cites W2947050213 @default.
• W2980772806 cites W591438761 @default.
• W2980772806 cites W2101442689 @default.
• W2980772806 doi "https://doi.org/10.1371/journal.pone.0223603" @default.
• W2980772806 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6799916" @default.
• W2980772806 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31626646" @default.
• W2980772806 hasPublicationYear "2019" @default.
• W2980772806 type Work @default.
• W2980772806 sameAs 2980772806 @default.
• W2980772806 citedByCount "34" @default.
• W2980772806 countsByYear W29807728062019 @default.
• W2980772806 countsByYear W29807728062020 @default.
• W2980772806 countsByYear W29807728062021 @default.
• W2980772806 countsByYear W29807728062022 @default.
• W2980772806 countsByYear W29807728062023 @default.
• W2980772806 crossrefType "journal-article" @default.
• W2980772806 hasAuthorship W2980772806A5007438752 @default.
• W2980772806 hasAuthorship W2980772806A5034436437 @default.
• W2980772806 hasAuthorship W2980772806A5044655005 @default.
• W2980772806 hasAuthorship W2980772806A5060521446 @default.
• W2980772806 hasAuthorship W2980772806A5064343783 @default.
• W2980772806 hasAuthorship W2980772806A5074889361 @default.
• W2980772806 hasAuthorship W2980772806A5074893779 @default.
• W2980772806 hasAuthorship W2980772806A5079544697 @default.
• W2980772806 hasAuthorship W2980772806A5079796813 @default.
• W2980772806 hasAuthorship W2980772806A5091189663 @default.
• W2980772806 hasBestOaLocation W29807728061 @default.
• W2980772806 hasConcept C126322002 @default.
• W2980772806 hasConcept C131872663 @default.
• W2980772806 hasConcept C156957248 @default.
• W2980772806 hasConcept C187212893 @default.
• W2980772806 hasConcept C188816634 @default.
• W2980772806 hasConcept C201903717 @default.
• W2980772806 hasConcept C207103383 @default.
• W2980772806 hasConcept C2777575956 @default.
• W2980772806 hasConcept C2778279030 @default.
• W2980772806 hasConcept C2779234561 @default.
• W2980772806 hasConcept C2780132546 @default.
• W2980772806 hasConcept C44249647 @default.
• W2980772806 hasConcept C54355233 @default.
• W2980772806 hasConcept C71924100 @default.
• W2980772806 hasConcept C72563966 @default.
• W2980772806 hasConcept C86803240 @default.
• W2980772806 hasConceptScore W2980772806C126322002 @default.
• W2980772806 hasConceptScore W2980772806C131872663 @default.
• W2980772806 hasConceptScore W2980772806C156957248 @default.
• W2980772806 hasConceptScore W2980772806C187212893 @default.
• W2980772806 hasConceptScore W2980772806C188816634 @default.
• W2980772806 hasConceptScore W2980772806C201903717 @default.
• W2980772806 hasConceptScore W2980772806C207103383 @default.
• W2980772806 hasConceptScore W2980772806C2777575956 @default.
• W2980772806 hasConceptScore W2980772806C2778279030 @default.
• W2980772806 hasConceptScore W2980772806C2779234561 @default.
• W2980772806 hasConceptScore W2980772806C2780132546 @default.
• W2980772806 hasConceptScore W2980772806C44249647 @default.
• W2980772806 hasConceptScore W2980772806C54355233 @default.
• W2980772806 hasConceptScore W2980772806C71924100 @default.
• W2980772806 hasConceptScore W2980772806C72563966 @default.
• W2980772806 hasConceptScore W2980772806C86803240 @default.
• W2980772806 hasFunder F4320309117 @default.
• W2980772806 hasIssue "10" @default.
• W2980772806 hasLocation W29807728061 @default.
• W2980772806 hasLocation W29807728062 @default.
• W2980772806 hasLocation W29807728063 @default.

• next